• Super-Enhancer Hijacking of LINC01977 Drives Early LUAD via

  2026-05-28

  Zhang et al. (2022) reveal that super-enhancer hijacking of the lncRNA LINC01977 promotes malignancy in early-stage lung adenocarcinoma (LUAD) by activating the canonical TGF-β/Smad3 signaling pathway. This mechanistic insight highlights LINC01977 as a potential therapeutic target and underscores the importance of epigenetic regulation in LUAD progression.

• Wogonin Modulates Macrophage Polarization in Osteoarthritis

  2026-05-28

  This study elucidates how wogonin alleviates osteoarthritis by modulating macrophage polarization and inflammatory signaling via the LSD1-p65 axis. The findings advance current understanding of immune cell crosstalk in OA and highlight methodological refinements in immunodetection workflows.

• Meropenem Trihydrate: Advanced Carbapenem Antibiotic Workflo

  2026-05-27

  Meropenem trihydrate from APExBIO accelerates resistance phenotyping and infection model optimization, with proven reproducibility in both gram-negative and gram-positive settings. This guide deciphers experimental enhancements, troubleshooting, and cutting-edge applications rooted in recent metabolomics insights.

• Amikacin (BAY416651): Mechanistic Insights & Granuloma Deliv

  2026-05-27

  Explore Amikacin (BAY416651) as a powerful bacterial protein synthesis inhibitor, with a focus on targeted delivery strategies and resistance research. This article offers an in-depth analysis distinct from existing resources, advancing practical assay design and translational research.

• ABT-737: Advanced BCL-2 Protein Inhibitor for Cancer Apoptos

  2026-05-26

  ABT-737, a potent BCL-2 protein inhibitor from APExBIO, enables precision control of apoptosis induction in diverse cancer models. Its robust activity profile, well-defined solubility, and compatibility with advanced imaging and functional assays make it a benchmark tool for translational oncology research.

• Deferasirox Fe3+ Chelate: Optimizing Iron Overload Research

  2026-05-26

  Deferasirox Fe3+ chelate, supplied by APExBIO, redefines iron overload treatment research with high-purity, DMSO-soluble performance tailored for beta-thalassemia and chronic anemia models. This article delivers advanced protocols, troubleshooting strategies, and actionable insights grounded in cutting-edge mechanistic studies.

• Honokiol: Advanced Workflows for NF-κB Pathway Inhibition

  2026-05-25

  Honokiol, a potent small molecule from APExBIO, is redefining in vitro cancer and inflammation research by combining robust antiangiogenic and antioxidant activities with workflow versatility. Explore optimized protocols, troubleshooting strategies, and data-driven insights that empower reproducible results in cell-based studies.

• Cefodizime: Third-Generation Cephalosporin for Broad Antimic

  2026-05-25

  Cefodizime is a third-generation cephalosporin antibiotic with potent, broad-spectrum activity and unique immunomodulatory effects. It inhibits bacterial cell wall synthesis by targeting PBPs and is stable against β-lactamases. Its efficacy and limitations are well-characterized for research applications.

• DCPS as a Biomarker in Diabetic Foot Ulcers: Mechanistic Ins

  2026-05-24

  Xiao et al. identify the m7G-related decapping scavenger enzyme (DCPS) as a novel biomarker and regulator of epithelial cell proliferation and migration in diabetic foot ulcers (DFU). Their multi-method approach connects RNA methylation machinery to impaired wound healing, providing a mechanistic foundation for future biomarker-driven interventions.

• Sodium-Induced Mitochondrial Dysfunction Drives NECSO Cell D

  2026-05-23

  The recent Nature Communications study by Qiao et al. delineates how sodium overload, mediated by TRPM4 channel activation, disrupts mitochondrial energy metabolism to trigger necrosis by sodium overload (NECSO). These insights clarify the link between Na+ influx, mitochondrial dysfunction, and energy failure in cell death, with implications for understanding pathologies marked by ionic imbalance.

• Macrophage EP4 Deficiency Accelerates Atherosclerosis via CD

  2026-05-22

  Tang et al. (2025) demonstrate that loss of the EP4 receptor in macrophages accelerates atherosclerosis progression by upregulating CD36-mediated lipid uptake and promoting pro-inflammatory polarization. This mechanistic insight advances understanding of plaque development and highlights molecular targets for cardiovascular intervention.

• Tivozanib (AV-951): Advanced Protocols for VEGFR Inhibition

  2026-05-22

  Tivozanib (AV-951) stands out in oncology research for its picomolar VEGFR-2 inhibition, enhanced selectivity, and robust anti-angiogenic effects. This guide details optimized workflows, troubleshooting strategies, and actionable insights for maximizing data reliability in renal cell carcinoma and solid tumor models.

• Direct Mouse Genotyping Kit Plus: Accelerating Precision Ass

  2026-05-21

  The Direct Mouse Genotyping Kit Plus streamlines mouse genotyping and transgene detection with rapid, purification-free workflows. Discover how this kit enables robust lineage-tracing and gene knockout validation, with actionable troubleshooting for reproducible, high-throughput research.

• PARP7 Inhibition Enhances IFN Signaling and Relieves EAE in

  2026-05-21

  Xu et al. reveal that PARP7 suppresses type I interferon signaling by promoting the degradation of STAT1/STAT2, and show that PARP7 inhibition alleviates experimental autoimmune encephalomyelitis (EAE) in mice. These findings illuminate a molecular mechanism linking PARP7 activity to neuroinflammation and point to novel therapeutic avenues for multiple sclerosis research.

• Metabolite Binding and Regulation of TET2: Protocol Advances

  2026-05-20

  Zhang et al. present an experimental protocol integrating biochemical assays with saturation transfer difference NMR to systematically identify and validate metabolite binding to the TET2 dioxygenase enzyme. Their workflow enables direct assessment of both activating and inhibitory metabolites, advancing the precision of studies on metabolism-epigenetics crosstalk.

15995 records 1/1067 page Next 12345 下5页 Last page